Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Cash from Operations (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Cash from Operations for 7 consecutive years, with 90496000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 25.61% to 90496000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 71098000.0 through Dec 2025, up 71.28% year-over-year, with the annual reading at 71098000.0 for FY2025, 71.28% up from the prior year.
  • Cash from Operations hit 90496000.0 in Q4 2025 for IDEAYA Biosciences, down from 142214000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 142214000.0 in Q3 2025 to a low of 121655000.0 in Q4 2024.
  • Historically, Cash from Operations has averaged 28843000.0 across 5 years, with a median of 26004000.0 in 2022.
  • Biggest five-year swings in Cash from Operations: tumbled 412.27% in 2024 and later soared 388.85% in 2025.
  • Year by year, Cash from Operations stood at 16657000.0 in 2021, then crashed by 40.3% to 23370000.0 in 2022, then dropped by 1.62% to 23748000.0 in 2023, then crashed by 412.27% to 121655000.0 in 2024, then rose by 25.61% to 90496000.0 in 2025.
  • Business Quant data shows Cash from Operations for IDYA at 90496000.0 in Q4 2025, 142214000.0 in Q3 2025, and 62474000.0 in Q2 2025.